Mechanism‐Based Modeling Approaches to Quantify the Effect of Immunogenicity on the Pharmacokinetics of Therapeutic Proteins in Drug Development
CPT: Pharmacometrics & Systems Pharmacology · 2025-09 · 14 (9) · 1431-1441
DOI: 10.1002/psp4.70080 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 22.07.2025. Verfasst von Paridhi Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Drug Development, Proteins, Models, Biological, Antibodies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Therapeutic protein administration in both preclinical and clinical studies can result in the formation of anti‐drug antibodies against the therapeutic protein. Anti‐drug antibody formation may alter the pharmacokinetics of the therapeutic protein, reduce its plasma concentrations, increase exposure variability, and may lead to a loss of efficacy and adverse events. In an effort to quantitatively understand the effect of anti‐drug antibodies on the concentration‐time profile of a therapeutic protein, as well as develop effective strategies to mitigate its impact in the preclinical and clinical development of therapeutic proteins, mathematical models have been developed to characterize the therapeutic protein pharmacokinetics and its modulation by anti‐drug antibodies in vivo. Here, we review several different mechanism‐based modeling frameworks, summarize their approaches to predict immunogenicity effects, and explore the merits and limitations of each model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- EMD Serono Research and Development Institute, Billerica, Massachusetts, USA.
- Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA.
ORCID-Profile: Paridhi Gupta, Josiah T Ryman, Vibha Jawa, Bernd Meibohm
Zitieren
APA
Gupta, P., Ryman, J. T., Jawa, V., & Meibohm, B. (2025). Mechanism‐Based Modeling Approaches to Quantify the Effect of Immunogenicity on the Pharmacokinetics of Therapeutic Proteins in Drug Development. CPT: Pharmacometrics & Systems Pharmacology, 14(9), 1431-1441. https://doi.org/10.1002/psp4.70080
Vancouver
Gupta P, Ryman JT, Jawa V, Meibohm B. Mechanism‐Based Modeling Approaches to Quantify the Effect of Immunogenicity on the Pharmacokinetics of Therapeutic Proteins in Drug Development. CPT: Pharmacometrics & Systems Pharmacology. 2025;14(9):1431-1441. doi:10.1002/psp4.70080
BibTeX
@article{Gupta2025,
author = {Gupta, Paridhi and Ryman, Josiah T and Jawa, Vibha and Meibohm, Bernd},
title = {Mechanism‐Based Modeling Approaches to Quantify the Effect of Immunogenicity on the Pharmacokinetics of Therapeutic Proteins in Drug Development},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2025},
volume = {14},
number = {9},
pages = {1431--1441},
doi = {10.1002/psp4.70080}
}
EUVIMED